PL4031157T3 - Szczepy bakteryjne, ich kompozycje i ich zastosowanie w leczeniu zaburzeń żołądkowo-jelitowych - Google Patents
Szczepy bakteryjne, ich kompozycje i ich zastosowanie w leczeniu zaburzeń żołądkowo-jelitowychInfo
- Publication number
- PL4031157T3 PL4031157T3 PL20792714.6T PL20792714T PL4031157T3 PL 4031157 T3 PL4031157 T3 PL 4031157T3 PL 20792714 T PL20792714 T PL 20792714T PL 4031157 T3 PL4031157 T3 PL 4031157T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- treatment
- bacterial strains
- gastrointestinal disorders
- gastrointestinal
- Prior art date
Links
- 208000018522 Gastrointestinal disease Diseases 0.000 title 1
- 230000001580 bacterial effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102019000016811A IT201900016811A1 (it) | 2019-09-20 | 2019-09-20 | Ceppi batterici, loro composizioni e loro uso per il trattamento di disturbi gastrointestinali |
| PCT/IB2020/058769 WO2021053636A1 (en) | 2019-09-20 | 2020-09-21 | Bacterial strains, their compositions and their use for the treatment of gastrointestinal disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4031157T3 true PL4031157T3 (pl) | 2024-05-06 |
Family
ID=69375783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20792714.6T PL4031157T3 (pl) | 2019-09-20 | 2020-09-21 | Szczepy bakteryjne, ich kompozycje i ich zastosowanie w leczeniu zaburzeń żołądkowo-jelitowych |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220339216A1 (pl) |
| EP (1) | EP4031157B1 (pl) |
| JP (1) | JP2023507049A (pl) |
| CN (1) | CN114728027A (pl) |
| AU (1) | AU2020347961A1 (pl) |
| BR (1) | BR112022004432A2 (pl) |
| CA (1) | CA3154976A1 (pl) |
| ES (1) | ES2975427T3 (pl) |
| IL (1) | IL291445A (pl) |
| IT (1) | IT201900016811A1 (pl) |
| MX (1) | MX2022003372A (pl) |
| PL (1) | PL4031157T3 (pl) |
| PT (1) | PT4031157T (pl) |
| WO (1) | WO2021053636A1 (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20131467A1 (it) | 2013-09-06 | 2015-03-07 | Sofar Spa | Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico |
| MA39710A (fr) | 2014-04-23 | 2015-10-29 | Sofar Spa | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin |
| MA45288A (fr) | 2016-06-08 | 2019-04-17 | Sofar Spa | Nouvelle utilisation médicale de probiotiques |
| IT201600122724A1 (it) | 2016-12-02 | 2018-06-02 | Sofar Spa | Exopolysaccharides and uses thereof |
| IT201600127498A1 (it) | 2016-12-16 | 2018-06-16 | Sofar Spa | Probiotici per uso nella diverticolosi e malattia diverticolare |
| IT201900020422A1 (it) * | 2019-11-05 | 2021-05-05 | Sofar Spa | Composizioni comprendenti ceppi di batteri per uso per aumentare la biodisponibilità degli amminoacidi derivanti da proteine |
| US11751597B2 (en) | 2019-11-05 | 2023-09-12 | Alfasigma S.P.A. | Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems |
| IT202100018740A1 (it) * | 2021-07-15 | 2023-01-15 | Sofar Spa | Uso di ceppi di batteri Lactobacillus paracasei nel trattamento di neonati |
| WO2024149375A1 (en) * | 2023-01-13 | 2024-07-18 | The Chinese University Of Hong Kong | Synbiotic compositions for improving immunity and for treating atopic dermatitis |
| WO2024176854A1 (ja) * | 2023-02-22 | 2024-08-29 | 株式会社 資生堂 | 皮膚の粘弾性に基づく短鎖脂肪酸量および腸管の免疫状態の評価方法 |
| CN117085042A (zh) * | 2023-10-20 | 2023-11-21 | 潍坊君薇生物科技有限责任公司 | 两歧双歧杆菌bl002后生元及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2855283B2 (ja) * | 1990-04-23 | 1999-02-10 | 株式会社ヤクルト本社 | 抗潰瘍剤およびその製造法 |
| JP3623977B2 (ja) * | 1993-10-29 | 2005-02-23 | 明治乳業株式会社 | 潰瘍性大腸炎治療剤 |
| US9084434B2 (en) * | 2006-09-27 | 2015-07-21 | Little Calumet Holdings Llc | Probiotic oral dosage forms |
| US20120064118A1 (en) * | 2009-03-05 | 2012-03-15 | Probiotical S.P.A. | Bacteria strains having a high anti-inflammatory activity |
| EP2251020A1 (en) * | 2009-05-11 | 2010-11-17 | Nestec S.A. | Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles |
| EA021890B1 (ru) * | 2009-11-02 | 2015-09-30 | Компани Жервэ Данон | Способ предотвращения и/или лечения болезни воспаленного кишечника, язвенного колита и болезни крона |
| ES2610908T3 (es) * | 2011-01-31 | 2017-05-04 | Synformulas Gmbh | Cepas de bifidobacterium bifidum para su aplicación en enfermedades gastrointestinales |
| KR101656208B1 (ko) * | 2014-11-04 | 2016-09-12 | 주식회사 쎌바이오텍 | 염증 질환 예방 또는 치료용 조성물 |
| WO2019019961A1 (zh) * | 2017-07-26 | 2019-01-31 | 海思科医药集团股份有限公司 | 防治消化道和/或皮肤反应的菌群及其应用 |
-
2019
- 2019-09-20 IT IT102019000016811A patent/IT201900016811A1/it unknown
-
2020
- 2020-09-21 US US17/761,980 patent/US20220339216A1/en active Pending
- 2020-09-21 EP EP20792714.6A patent/EP4031157B1/en active Active
- 2020-09-21 PL PL20792714.6T patent/PL4031157T3/pl unknown
- 2020-09-21 BR BR112022004432A patent/BR112022004432A2/pt unknown
- 2020-09-21 JP JP2022518388A patent/JP2023507049A/ja active Pending
- 2020-09-21 ES ES20792714T patent/ES2975427T3/es active Active
- 2020-09-21 AU AU2020347961A patent/AU2020347961A1/en active Pending
- 2020-09-21 CN CN202080065521.9A patent/CN114728027A/zh active Pending
- 2020-09-21 WO PCT/IB2020/058769 patent/WO2021053636A1/en active Application Filing
- 2020-09-21 MX MX2022003372A patent/MX2022003372A/es unknown
- 2020-09-21 CA CA3154976A patent/CA3154976A1/en active Pending
- 2020-09-21 PT PT207927146T patent/PT4031157T/pt unknown
-
2022
- 2022-03-16 IL IL291445A patent/IL291445A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IT201900016811A1 (it) | 2021-03-20 |
| AU2020347961A1 (en) | 2022-03-31 |
| CN114728027A (zh) | 2022-07-08 |
| US20220339216A1 (en) | 2022-10-27 |
| JP2023507049A (ja) | 2023-02-21 |
| EP4031157A1 (en) | 2022-07-27 |
| CA3154976A1 (en) | 2021-03-25 |
| ES2975427T3 (es) | 2024-07-05 |
| WO2021053636A1 (en) | 2021-03-25 |
| BR112022004432A2 (pt) | 2022-05-31 |
| EP4031157B1 (en) | 2024-02-28 |
| MX2022003372A (es) | 2022-04-11 |
| IL291445A (en) | 2022-05-01 |
| PT4031157T (pt) | 2024-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL291460A (en) | Bacterial strains, their compositions and their use in the treatment of gastrointestinal disorders | |
| IL291445A (en) | Bacterial strains, their compositions and their use in the treatment of gastrointestinal disorders | |
| IL271085A (en) | Bacteria to treat disorders | |
| EP3584308A3 (en) | Compositions and methods | |
| IL285782A (en) | Compounds, compositions, and methods for treating disease | |
| IL291463A (en) | The compositions based on bacterial strains and their use as anti-inflammatories | |
| EP2440210A4 (en) | METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES | |
| EP3411504A4 (en) | ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE-1 DIABETES | |
| EP3474861A4 (en) | COMPOUNDS COMPRISING HMOS FOR THE PREVENTION AND / OR TREATMENT OF VIRAL AND / OR BACTERIAL INFECTIONS. | |
| IL284414A (en) | Methods and preparations for the treatment of Fabry disease | |
| EP3818085A4 (en) | COMPOSITIONS AND THEIR USES FOR THE TREATMENT OF DISEASES OR DISORDERS | |
| EP3675871A4 (en) | COMPOSITIONS AND METHODS OF TREATMENT OF FIBROTIC DISEASES | |
| EP3935078A4 (en) | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF RETINOPATHIES | |
| EP3755319A4 (en) | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MUSCLE DISEASES | |
| ZA201907487B (en) | Compositions and treatment procedures for the treatment of pathogenic infections | |
| IL270927B (en) | fused 5,6 bicyclic compounds and compounds for the treatment of parasitic diseases | |
| MX2020001632A (es) | Composiciones que comprenden cepas bacterianas. | |
| EP3661502A4 (en) | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF MEDICAL CONDITIONS AND THEIR USES | |
| EP3856147A4 (en) | PROBIOTIC METHODS AND COMPOSITIONS FOR THE TREATMENT OF BONE LESIONS | |
| GB201915828D0 (en) | Compounds, compositions and therapeutic uses thereof | |
| EP3820477A4 (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES | |
| EP4040991A4 (en) | TREATMENTS FOR GASTROINTESTINAL DISEASES | |
| EP3897579A4 (en) | COMPOSITIONS, DEVICES AND METHODS FOR TREATING OVERDOSE AND REWARD-RELATED DISORDERS | |
| GB2579240B (en) | New processes, compositions and medical uses | |
| EP3585411A4 (en) | IL-22BP COMPOSITIONS AND METHODS OF TREATMENT OF DISEASES THEREOF |